Showing results (21-30 of 101) with videos related to
Sort By:
Pageof 11
Nature Communications|August 16, 2019
Dissecting the heterogeneity of DENV vaccine-elicited cellular immunity using single-cell RNA sequencing and metabolic profilingAdam T Waickman, Kaitlin Victor, Tao Li, et al.Frontiers in Immunology|August 16, 2021
Longitudinal Analysis of Dengue Virus-Specific Memory T Cell Responses and Their Association With Clinical Outcome in Subsequent DENV InfectionLuis Alberto Sanchez-Vargas, Kathryn B Anderson, Anon Srikiatkhachorn, et al.Plos One|August 11, 2012
HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responsesNicholas J Steers, Silvia Ratto-Kim, Mark S de Souza, et al.Human Immunology|July 14, 2020
Next-generation sequencing of 11 HLA loci in a large dengue vaccine cohort from the PhilippinesAviva Geretz, Lauryn Cofer, Philip K Ehrenberg, et al.Journal of Immunological Methods|January 17, 2002
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assaysJeffrey R Currier, Ellen G Kuta, Ellen Turk, et al.Open Forum Infectious Diseases|January 6, 2025
Dengue Virus Structural Proteins Are Expressed on the Surface of DENV-Infected Cells and Are a Target for Antibody-Dependent Cellular PhagocytosisMitchell J Waldran, Elizabeth A Kurtz, Chad J Gebo, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 27, 2025
The MAIT cell response to controlled oral enterotoxigenic E. coli challengeKerri G Lal, Dohoon Kim, Matthew Creegan, et al.JCI Insight|June 2, 2022
mRNA-1273 vaccination protects against SARS-CoV-2-elicited lung inflammation in nonhuman primatesAdam T Waickman, Kaitlin Victor, Krista Newell, et al.Vaccine|February 21, 2026
Humoral and cellular responses to a tetravalent dengue vaccine (TAK-003) in adults from a dengue non-endemic region: An open-label phase 2 trialSanja Mandaric, Heather Friberg, Raphael Gottardo, et al.Journal of Virology|September 28, 2007
A high viral burden predicts the loss of CD8 T-cell responses specific for subdominant gag epitopes during chronic human immunodeficiency virus infectionChristof Geldmacher, Clive Gray, Martha Nason, et al.Pageof 11